Shares of Heska Corp. (NASDAQ:HSKA) hit a new 52-week high during trading on Tuesday . The stock traded as high as $54.59 and last traded at $53.72, with a volume of 89,832 shares changing hands. The stock had previously closed at $52.44.

Several analysts recently commented on HSKA shares. Zacks Investment Research upgraded Heska Corp. from a “hold” rating to a “buy” rating and set a $48.00 target price on the stock in a report on Wednesday, July 13th. Sidoti started coverage on Heska Corp. in a report on Friday, July 1st. They issued a “buy” rating and a $49.00 target price on the stock. TheStreet upgraded Heska Corp. from a “hold” rating to a “buy” rating in a report on Wednesday, May 25th. Gabelli cut Heska Corp. from a “buy” rating to a “hold” rating in a report on Thursday, August 4th. Finally, B. Riley reissued a “buy” rating and issued a $42.50 price target on shares of Heska Corp. in a research note on Monday, May 9th. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $52.83.

The firm has a market cap of $370.56 million and a PE ratio of 54.61. The stock’s 50-day moving average is $47.08 and its 200 day moving average is $36.77.

Heska Corp. (NASDAQ:HSKA) last released its quarterly earnings results on Wednesday, August 3rd. The company reported $0.35 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.17. The business earned $30 million during the quarter, compared to analysts’ expectations of $28.47 million. The firm’s quarterly revenue was up 25.5% on a year-over-year basis. On average, equities research analysts anticipate that Heska Corp. will post $1.12 EPS for the current year.

In related news, CEO Kevin S. Wilson sold 3,779 shares of the firm’s stock in a transaction dated Wednesday, July 20th. The stock was sold at an average price of $44.02, for a total transaction of $166,351.58. Following the transaction, the chief executive officer now directly owns 140,756 shares of the company’s stock, valued at approximately $6,196,079.12. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Steve Asakowicz sold 4,698 shares of the firm’s stock in a transaction dated Tuesday, August 9th. The shares were sold at an average price of $52.55, for a total value of $246,879.90. Following the transaction, the executive vice president now directly owns 12,858 shares in the company, valued at $675,687.90. The disclosure for this sale can be found here.

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.